vs

Side-by-side financial comparison of Baxter International (BAX) and CME Group (CME). Click either name above to swap in a different company.

Baxter International is the larger business by last-quarter revenue ($2.7B vs $1.9B, roughly 1.4× CME Group). CME Group runs the higher net margin — 0.1% vs -0.6%, a 0.6% gap on every dollar of revenue. On growth, CME Group posted the faster year-over-year revenue change (14.5% vs 3.0%). Over the past eight quarters, CME Group's revenue compounded faster (10.8% CAGR vs -15.8%).

Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois.

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

BAX vs CME — Head-to-Head

Bigger by revenue
BAX
BAX
1.4× larger
BAX
$2.7B
$1.9B
CME
Growing faster (revenue YoY)
CME
CME
+11.5% gap
CME
14.5%
3.0%
BAX
Higher net margin
CME
CME
0.6% more per $
CME
0.1%
-0.6%
BAX
Faster 2-yr revenue CAGR
CME
CME
Annualised
CME
10.8%
-15.8%
BAX

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
BAX
BAX
CME
CME
Revenue
$2.7B
$1.9B
Net Profit
$-15.0M
$1.2M
Gross Margin
33.0%
Operating Margin
2.4%
0.1%
Net Margin
-0.6%
0.1%
Revenue YoY
3.0%
14.5%
Net Profit YoY
20.7%
EPS (diluted)
$-0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BAX
BAX
CME
CME
Q1 26
$2.7B
$1.9B
Q4 25
$3.0B
$1.6B
Q3 25
$2.8B
$1.5B
Q2 25
$2.8B
$1.7B
Q1 25
$2.6B
$1.6B
Q4 24
$533.0M
$1.5B
Q3 24
$2.7B
$1.6B
Q2 24
$3.8B
$1.5B
Net Profit
BAX
BAX
CME
CME
Q1 26
$-15.0M
$1.2M
Q4 25
$-1.1B
$1.2B
Q3 25
$-46.0M
$908.0M
Q2 25
$91.0M
$1.0B
Q1 25
$126.0M
$956.2M
Q4 24
$-512.0M
$874.6M
Q3 24
$140.0M
$912.8M
Q2 24
$-314.0M
$883.2M
Gross Margin
BAX
BAX
CME
CME
Q1 26
33.0%
Q4 25
19.4%
Q3 25
33.5%
Q2 25
35.3%
Q1 25
32.8%
Q4 24
25.0%
Q3 24
38.3%
Q2 24
37.5%
Operating Margin
BAX
BAX
CME
CME
Q1 26
2.4%
0.1%
Q4 25
-24.5%
61.8%
Q3 25
6.1%
63.3%
Q2 25
6.8%
66.7%
Q1 25
2.2%
67.5%
Q4 24
-25.5%
62.1%
Q3 24
5.7%
64.6%
Q2 24
-5.0%
65.3%
Net Margin
BAX
BAX
CME
CME
Q1 26
-0.6%
0.1%
Q4 25
-37.9%
71.7%
Q3 25
-1.6%
59.1%
Q2 25
3.2%
60.6%
Q1 25
4.8%
58.2%
Q4 24
-96.1%
57.3%
Q3 24
5.2%
57.6%
Q2 24
-8.2%
57.6%
EPS (diluted)
BAX
BAX
CME
CME
Q1 26
$-0.03
Q4 25
$-2.21
$3.24
Q3 25
$-0.09
$2.49
Q2 25
$0.18
$2.81
Q1 25
$0.25
$2.62
Q4 24
$-0.99
$2.40
Q3 24
$0.27
$2.50
Q2 24
$-0.62
$2.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BAX
BAX
CME
CME
Cash + ST InvestmentsLiquidity on hand
$2.4B
Total DebtLower is stronger
$3.4B
Stockholders' EquityBook value
Total Assets
$202.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BAX
BAX
CME
CME
Q1 26
$2.4B
Q4 25
$2.0B
$4.5B
Q3 25
$1.7B
$2.6B
Q2 25
$1.7B
$2.1B
Q1 25
$2.3B
$1.5B
Q4 24
$1.8B
$3.0B
Q3 24
$1.4B
$2.4B
Q2 24
$2.1B
$1.9B
Total Debt
BAX
BAX
CME
CME
Q1 26
$3.4B
Q4 25
$9.5B
Q3 25
Q2 25
Q1 25
Q4 24
$10.4B
Q3 24
$10.4B
Q2 24
$10.4B
Stockholders' Equity
BAX
BAX
CME
CME
Q1 26
Q4 25
$6.1B
$28.7B
Q3 25
$7.2B
$28.2B
Q2 25
$7.3B
$27.7B
Q1 25
$7.1B
$27.0B
Q4 24
$7.0B
$26.5B
Q3 24
$7.9B
$28.2B
Q2 24
$7.6B
$27.6B
Total Assets
BAX
BAX
CME
CME
Q1 26
$202.0B
Q4 25
$20.1B
$198.4B
Q3 25
$21.1B
$187.1B
Q2 25
$21.0B
$179.9B
Q1 25
$21.3B
$157.8B
Q4 24
$25.8B
$137.4B
Q3 24
$26.7B
$137.8B
Q2 24
$26.3B
$123.4B
Debt / Equity
BAX
BAX
CME
CME
Q1 26
Q4 25
1.55×
Q3 25
Q2 25
Q1 25
Q4 24
1.49×
Q3 24
1.33×
Q2 24
1.37×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BAX
BAX
CME
CME
Operating Cash FlowLast quarter
Free Cash FlowOCF − Capex
$76.0M
FCF MarginFCF / Revenue
2.8%
Capex IntensityCapex / Revenue
5.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BAX
BAX
CME
CME
Q1 26
Q4 25
$584.0M
$1.1B
Q3 25
$237.0M
$968.1M
Q2 25
$217.0M
$1.1B
Q1 25
$-193.0M
$1.1B
Q4 24
$488.0M
$1.0B
Q3 24
$253.0M
$1.0B
Q2 24
$115.0M
$776.9M
Free Cash Flow
BAX
BAX
CME
CME
Q1 26
$76.0M
Q4 25
$1.1B
Q3 25
$949.7M
Q2 25
$1.0B
Q1 25
$1.1B
Q4 24
$991.7M
Q3 24
$973.2M
Q2 24
$758.7M
FCF Margin
BAX
BAX
CME
CME
Q1 26
2.8%
Q4 25
66.8%
Q3 25
61.8%
Q2 25
61.5%
Q1 25
67.1%
Q4 24
65.0%
Q3 24
61.4%
Q2 24
49.5%
Capex Intensity
BAX
BAX
CME
CME
Q1 26
5.1%
Q4 25
2.0%
Q3 25
1.2%
Q2 25
1.1%
Q1 25
0.9%
Q4 24
1.7%
Q3 24
1.9%
Q2 24
1.2%
Cash Conversion
BAX
BAX
CME
CME
Q1 26
Q4 25
0.96×
Q3 25
1.07×
Q2 25
2.38×
1.03×
Q1 25
-1.53×
1.17×
Q4 24
1.16×
Q3 24
1.81×
1.10×
Q2 24
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons